|Bid||64.26 x 300|
|Ask||64.28 x 200|
|Day's Range||63.91 - 65.48|
|52 Week Range||63.91 - 68.72|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 23, 2017 - Oct 27, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||80.71|
Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.
SAN DIEGO, Aug. 15, 2017 /PRNewswire/ -- NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today the appointment of Rajesh (Raj) J. Asarpota as the Company's new executive vice president and chief financial officer (CFO), effective September 1, 2017. As a member of NuVasive's global executive team, Mr. Asarpota will be responsible for the Company's global finance functions including accounting, FP&A, treasury and tax.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NuVasive, Inc. Here are 5 ETFs with the largest exposure to NUVA-US. Comparing the performance and risk of NuVasive, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)